RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.

Add to Collection
2022 Oct Others Fist_Author_Year_PM

Full Author : ['Branch, Kelley R H', 'Dagenais, Gilles R', 'Avezum, Alvaro', 'Basile, Jan', 'Conget, Ignacio', 'Cushman, William C', 'Jansky, Petr', 'Lakshmanan, Mark', 'Lanas, Fernando', 'Leiter, Lawrence A', 'Pais, Prem', 'Pogosova, Nana', 'Raubenheimer, Peter J', 'Ryden, Lars', 'Shaw, Jonathan E', 'Sheu, Wayne H H', 'Temelkova-Kurktschiev, Theodora', 'Bethel, M Angelyn', 'Gerstein, Hertzel C', 'Chinthanie, Ramasundarahettige', 'Probstfield, Jeffrey L']
Journal Title : European journal of heart failure
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

AIMS: People with diabetes are at high risk for cardiovascular events including heart failure (HF). We examined the effect of the glucagon-like peptide 1 agonist dulaglutide on incident HF events and other cardiovascular outcomes in those with or without .....

Keywords : ["without heart failure", "rewind randomize trial", "heart failure outcome", "posthoc analysis", "patient", "dulaglutide", "cardiovascular"]